In non-HBV-related HCC specimens, upregulation of HOTTIP, and the associated increase in HOXA13, is an indication of metastatic potential, increased probability of disease recurrence following liver transplantation, and poor overall survival (67, 68). The gene discussed is HOXA13; the disease is hepatocellular carcinoma.